VBI Vaccines Inc/BC Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2015 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
VBI Vaccines Inc/BC quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2015 to Q4 2023.
  • VBI Vaccines Inc/BC Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $117M, a 18.4% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $117M +$18.1M +18.4% Dec 31, 2023 10-K 2024-04-16
Q4 2022 $98.6M +$11.4M +13.1% Dec 31, 2022 10-K 2024-04-16
Q4 2021 $87.2M +$18.9M +27.8% Dec 31, 2021 10-K 2023-03-13
Q4 2020 $68.2M +$15.2M +28.8% Dec 31, 2020 10-K 2022-03-07
Q4 2019 $53M +$10.9M +25.8% Dec 31, 2019 10-K 2021-03-02
Q4 2018 $42.1M +$14.7M +53.5% Dec 31, 2018 10-K 2020-03-05
Q4 2017 $27.4M +$49.4M Dec 31, 2017 10-K 2019-02-25
Q4 2016 -$21.9M -$16.2M -280% Dec 31, 2016 10-K 2018-02-26
Q4 2015 -$5.77M Dec 31, 2015 10-K 2017-03-20
* An asterisk sign (*) next to the value indicates that the value is likely invalid.